General Counsel & Corporate Secretary (5) · Ovid Therapeutics Inc. (OVID)

Thomas Perone

A named executive officer of Ovid Therapeutics in every fiscal year CompBrief holds from FY2020 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$1,068,446

Salary $494,940Stock awards $0

FY2021: $638,077

3rd of 3 named executive officers at Ovid Therapeutics by FY2023 total.

3 named officers on file for Ovid Therapeutics, FY2023

Thomas Perone’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Ovid Therapeutics’s whole pay program stands against its peers

  • Ovid Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on OVID→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 24, 2024 (DEF 14A).

Free

Get Thomas Perone’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Thomas Perone compensation by year

Ovid Therapeutics Summary Compensation Table · all 3 fiscal years held
In US dollars, as Ovid Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021FY2023
Salary$440,000$457,600$494,940
Bonus$0—$0
Stock awards$0—$0
Option awards$842,145—$322,735
Non-equity incentive$176,000$162,906$237,571
Pension and deferred compensation$0—$0
All other$17,371$11,600$13,200
Total$1,475,516$638,077$1,068,446

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Ovid Therapeutics Inc. DEF 14A filed April 24, 2024, accession 0000950170-24-047673, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Ovid Therapeutics Inc. filed document, accession 0000950170-24-047673. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2024.

$1.5M
$638K
$1.1M
FY20
FY21
FY23
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
Option1,563—$4.15
Option43,750—$2.82
Option91,146—$2.72
Option4,234—$3.22
Option5,834—$3.22
Option175,000—$2.50

Per the Outstanding Equity Awards at Fiscal Year-End table in Ovid Therapeutics Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Ovid Therapeutics’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
DPhil Jeremy LevinChief Executive Officer$2,136,546
Jeffrey RonaChief Business & Financial Officer$1,083,970
Thomas Perone · this pageGeneral Counsel & Corporate Secretary (5)$1,068,446

The full Ovid Therapeutics compensation record

free company brief

This page is one person within Ovid Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Ovid Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Thomas Perone's compensation dossier · One-time report. No refunds.